MediaToday Newspapers Latest Editions

MaltaToday 18 December 2024 MIDWEEK

Issue link: https://maltatoday.uberflip.com/i/1530669

Contents of this Issue

Navigation

Page 9 of 11

10 OPINION maltatoday | WEDNESDAY • 18 DECEMBER 2024 Morpheus makes use of distraction as a pain management technique PAIN is an unavoidable part of life, but for millions of peo- ple worldwide, it goes beyond a fleeting sensation. Chronic pain becomes a persistent obstacle, affecting daily routines, relation- ships, and mental health. De- spite advancements in medicine, traditional solutions—primarily medication—often fall short. They provide temporary relief but come with side effects, risks of dependency, and limited ac- cessibility. The Morpheus project, sup- ported by the Fusion R&I Technology Development Pro- gramme LITE, tackles this chal- lenge head-on with a bold new approach that promises effec- tive, drug-free pain relief. The transformative power of Morpheus lies in its ability to recondition how the brain pro- cesses pain. At its core, pain is not just a physical sensation but an experience shaped by atten- tion and emotion. Morpheus redirects the brain's focus by engaging the mind in an im- mersive, carefully tailored Vir- tual Reality (VR) environment, leaving less room to process pain signals. What makes this technology revolutionary is its dynamic, re- al-time adaptability. Morpheus monitors physiological and emotional states—such as heart rate—through wearable biosen- sors and adjusts the virtual ex- perience accordingly. Calming scenarios are introduced when stress is detected, while interac- tive challenges re-engage users if they appear bored or disen- gaged. This precision transforms dis- traction therapy into an intelli- gent, personalised tool for pain relief. The results of Morpheus have been nothing short of astonish- ing. Clinical trials reveal that Morpheus reduces perceived pain by 39%, a significant im- provement over traditional methods. The benefits extend beyond pain relief, with partici- pants reporting a 38% reduction in anxiety and a 14% decrease in depression. These results underline the technology's holistic impact, which addresses the physical discomfort and the psychologi- cal burden of chronic pain. For many, this isn't just relief—it's a return to control over their lives. These results offer a ray of hope and reassurance to those struggling with chronic pain, showing that adequate relief is within reach. Morpheus's accessibility boosts its potential. Unlike many pain management sys- tems that rely on costly or spe- cialised equipment, Morpheus operates on affordable, widely available devices like smart- phones, smartwatches, and VR headsets. This thoughtful design ensures that the technology isn't limited to advanced healthcare facilities or affluent patients. Instead, it can be deployed in diverse set- tings, from hospitals and clinics to private homes, offering relief to children, adults, and even those in under-resourced com- munities. By lowering the barri- er to entry, Morpheus is democ- ratising access to cutting-edge pain management, making it a practical and accessible solution for healthcare professionals and patients alike. This innovation has been made possible through the Fu- sion R&I Technology Develop- ment Programme LITE, which supports projects that push the boundaries of science and tech- nology. The team behind Morpheus, based at the University of Mal- ta, is refining the system to meet rigorous medical standards and laying the groundwork for glob- al adoption. Collaborations with inter- national health-tech firms are underway, and efforts to secure widespread-use certifications are progressing. These steps are critical to ensuring that Mor- pheus reaches the people who need it most, wherever they are. Looking to the future, Mor- pheus's possibilities extend far beyond its current appli- cations. While the system is already proving invaluable for managing chronic pain, it holds promise for other areas, such as post-surgical recovery, reha- bilitation, and the treatment of conditions like fibromyalgia. The technology's adaptabil- ity makes it a versatile tool that can evolve to meet various therapeutic needs. The team is actively expanding the VR con- tent, creating scenarios that distract from pain and promote relaxation, resilience, and emo- tional healing. This adaptability and potential for growth make Morpheus an exciting prospect for the future of healthcare, offering a wide range of therapeutic benefits to patients and healthcare profes- sionals alike. Morpheus isn't just about pain relief; it's about changing how we think about healthcare. By addressing pain within the brain's network of perception and attention, the project offers a glimpse into a future where medicine focuses on empower- ing individuals rather than just managing symptoms. This vision, supported by the Fusion R&I Technology De- velopment Programme LITE, is a testament to the potential of combining innovation with compassion. Moreover, the widespread adoption of Morpheus could re- duce the burden on healthcare systems and lower long-term healthcare costs. Rewiring pain: The AI-powered solution transforming lives Prof. Alexiei Dingli is Professor of Artificial Intelligence Alexiei Dingli

Articles in this issue

Archives of this issue

view archives of MediaToday Newspapers Latest Editions - MaltaToday 18 December 2024 MIDWEEK